Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
63.73%
Change (1 year)
Categories
Immunovant (IMVT) - Cash on Hand
Cash on Hand as of December 2023 : $0.69 B
According to Immunovant's latest financial reports the company has $0.69 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunovant - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.37 B | -23.75% |
| 2022-03-31 | $0.49 B | 23.41% |
| 2021-03-31 | $0.40 B | 297.87% |
| 2020-03-31 | $0.10 B | |
| 2018-12-31 | $0.32 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -69.87% | 🇺🇸 USA |